What sector does SAMJIN PHARMACEUTICAL CO.,LTD belong to?

SAMJIN PHARMACEUTICAL CO.,LTD operates in the Pharmaceuticals sector, specifically the Pharmaceuticals industry, and is listed on the US markets.

What is the current share price of 005500?

As of the latest available quote, 005500 traded at ₩18,440.00. This price is delayed and cached for about 15 minutes.

What is the P/E ratio of 005500?

SAMJIN PHARMACEUTICAL CO.,LTD has a price-to-earnings (P/E) ratio of about 10.67. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.

What is the market capitalisation of 005500?

The market capitalisation of SAMJIN PHARMACEUTICAL CO.,LTD is approximately ₩233.71B.

Is SAMJIN PHARMACEUTICAL CO.,LTD profitable?

For its latest reported financial year, SAMJIN PHARMACEUTICAL CO.,LTD recorded a net profit margin of about 7.99%.

Does 005500 pay a dividend?

SAMJIN PHARMACEUTICAL CO.,LTD currently has a dividend yield of about 3.02%.

What is the return on equity (ROE) of 005500?

SAMJIN PHARMACEUTICAL CO.,LTD has a return on equity (ROE) of about 7.95%. ROE measures how much profit a company generates relative to shareholders' equity.

What is the 52-week high and low of 005500?

Over the past 52 weeks, 005500 has traded between a low of ₩16,580.00 and a high of ₩25,900.00.

SAMJIN PHARMACEUTICAL CO.,LTD

005500 KRX Pharmaceuticals Pharmaceuticals

KOSPI

₩18,440.00

-0.59%

Delayed · cached 15 min

Fair value analysis

005500

SAMJIN PHARMACEUTICAL CO.,LTD

₩18,440.00

Close used for this calculation

₩25,337.29Fair value

Financial DNA Score

Profitability · Returns · Balance Sheet · Efficiency · Growth

55/100

Profitability6/25

Returns8/25

Balance Sheet16/25

Efficiency25/25

Growth13/25

Good

Quality radar

Consensus fair value

₩25,337.29

Below FV

▲ +37.4% against the close used

Model range ₩7,100.32 – ₩34,560.00

The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₩7,100.32Fair value₩25,337.29Bull₩34,560.00

FairClose

52-week traded range

52W low ₩17,010.0052W high ₩24,700.00

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading below the consensus fair value

SAMJIN PHARMACEUTICAL CO.,LTD closed at ₩18,440.00, 27.2% below the consensus fair value of ₩25,337.29 drawn from 8 valuation models.

Financial DNA score 55/100 — Good. P/E of 10.7x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation

₩32,387.10

+75.6%

Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10

g=8%, r=10%, tg=3%, n=10yr

Graham Number

₩28,382.37

+53.9%

√(22.5 × EPS × BVPS)

EPS=1728, BVPS=20719.1

P/E Fair Value

₩34,560.00

+87.4%

EPS × 20x (sector P/E)

EPS=1728, Sector P/E=20x

EV/EBITDA

₩12,098.91

-34.4%

(EBITDA × 10x − Net Debt) ÷ Shares

EBITDA=23.18B

Dividend Discount (DDM)

₩7,100.32

-61.5%

D1 ÷ (r − g) where D1 = D0×(1+g)

D0=556.89, r=10%, g=2%

Book Value (P/B)

₩14,651.36

-20.5%

BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]

BVPS=20719.1, ROE=8%, g=3%, r=10%

Reverse DCF

₩18,440.00

+0.0%

Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV

Implied: -1.4% | Historical: 0%

Margin of Safety

₩23,832.37

+29.2%

Avg(DCF, Graham, P/E) × 75% (25% safety buffer)

Avg fair value=31776.49, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Fair value analysis

Consensus fair value

Price target range & 52-week position

Valuation summary

All valuation models

Equity Timer